Breezy Hill Update 8810
- The next chicken day is scheduled for Aug 20, a Friday. I will be sending out a separate email to those getting chickens. I don't know for sure how many we will have available. Stay tuned.
- Goldie the new cow is working out pretty well, so far.
- Wheat prices have skyrocketed due to the drought in Russia. Our crop is in the freezer and is still $.80/#. Makes awesome pancakes and bread. Check out the Easy Bread Recipe on our web site.
- We have two tubs of lard. Twenty dollars each.
- We have a couple of yogurt makers. Twenty-four dollars each.
- We still have the freezer, but someone may be interested. Will know this week.
Please help get control away from the large corporations. Some have asked, “What can I do?”. Here’s your chance. http://action.foodandwaterwatch.org/p/dia/action/public/?action_KEY=2535
Here’s another link with info about Vit K and grass “finished” beef. http://www.healthy-eating-politics.com/grass-fed-beef.html
Here are the important markers for heart health. I got a “Cardio-Vascular Profile -2” test and it had most of these. A good resource is a book by Dr Mark Liponis, Ultra-Prevention. This is an informative site. http://www.healthy-eating-politics.com/blood-test-results.html
Read this one and email me and I will put you on the list for a “Dirt Hog”. I’m still looking to find some that meet (meat) my requirements. http://www.grist.org/article/meat-wagon-filthy-swine
Here is some statin news from Dr Douglass.
A new analysis finds major problems with the Big Pharma-funded study used to push statins on millions of healthy people -- including glaring financial conflicts, inconsistent data and a too-quick move to end the trial once they got the result they were looking for.
And that adds up to a trial that could have been seriously biased, according to the new analysis.
A company-funded trial... biased??? You don't say!
Of course, I wasn't at all surprised to read in the Archives of Internal Medicine that nine of the 14 main researchers behind the infamous JUPITER trial had financial ties to AstraZeneca. That's the company that makes Crestor, the statin used in the study, and its money paid for this piece of... well, let's call it a piece of research.
What's more, the lead JUPITER researcher had a conflict so glaring he shouldn't have been allowed within a mile of this thing. The analysts say Harvard Medical School's Dr. Paul Ridker holds a patent that could earn him huge piles of cash once Crestor is put into wider use.
And guess what? As a result of his study, Crestor is being put into wider use -- because the FDA has approved a dangerous scheme to give this cholesterol med to millions of healthy people with no hint of a cholesterol problem.
But while the study found that Crestor might lower heart disease risk in these people, the researchers conveniently left out data showing that the drug didn't actually lower the rates of death by heart attack and stroke, according to the new analysis.
Another new analysis in the same journal looked at 11 studies -- including JUPITER -- and found that statins didn't help "high-risk" patients with no signs of heart disease to live even a second longer.
And of course, we don't know the long-term effects of Crestor in healthy patients -- because the researchers pulled the plug on JUPITER more than two years ahead of schedule.
With so many obvious problems, this trial wasn't a piece of research.
It was a piece of something else entirely.
Tearing bad research into pieces,
William Campbell Douglass II, M.D.
that's it from the hill. Art and Debra